Evidence map›Paper›PMID 30326954›Full record

Trial reportMicrobiome2018

Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants.

Katri Korpela, Anne Salonen, Outi Vepsäläinen, Marjo Suomalainen, Carolin Kolmeder, Markku Varjosalo, Sini Miettinen, Kaarina Kukkonen, Erkki Savilahti, Mikael Kuitunen and 1 more

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Microbiome, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 129 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 12 pooled it
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00298337 phase2 / phase3unknown statusnot on this map

Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008

TypeinterventionalSponsorUniversity of HelsinkiRan1999 to 2007ConditionsAtopic Dermatitis, Food Hypersensitivity, Allergic Rhinitis, Seasonal, Allergic ConjunctivitisArmsMixture of probiotic bacteria and prebiotic oligosaccharide
NCT04171466 nacompletednot on this mapstarted 2020, after this paper: background citation

A Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy of a Multi-strain Synbiotic (SH-DS01) to Restore Gut Barrier Integrity and Gut Microbiota Composition After Antibiotic Administration.

TypeinterventionalSponsorSeed HealthRan2020 to 2022Enrolled46ConditionsAntibiotic Side Effect, Antibiotic-associated Diarrhea, Antibiotic-induced Dysbiosis, Antibiotic-induced Epithelial Barrier DisintegrityArmsCiprofloxacin + Metronidazole, SH-DS01, Placebo
3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 12 syntheses or guidelines pooled it, 240 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Efficacy ofFrontiers in nutrition · 2026
    Trial
  14. Trial
  15. Trial
  16. Evaluation of efficacy and safety ofFrontiers in immunology · 2024
    Trial
  17. Trial
  18. Effect ofNutrients · 2023
    Trial
  19. Does Multi-Strain Probiotic Supplementation Impact the Effort Capacity of Competitive Road Cyclists?International journal of environmental research and public health · 2022
    Trial
  20. Review

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Katri KorpelaImmunobiology Research Programme, Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland. katri.korpela@helsinki.fi.ORCID 0000-0001-5031-2713
Anne SalonenImmunobiology Research Programme, Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.
Outi VepsäläinenDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
Marjo SuomalainenDepartment of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
Carolin KolmederDepartment of Microbiome Science, Max Planck Institute for Developmental Biology, Tübingen, Germany.
Markku VarjosaloInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Sini MiettinenInstitute of Biotechnology, University of Helsinki, Helsinki, Finland.
Kaarina KukkonenSkin and Allergy Hospital, Department of Paediatrics, Helsinki University Hospital, Helsinki, Finland.
Erkki SavilahtiChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Mikael KuitunenChildren's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Willem M de VosImmunobiology Research Programme, Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.
University of Helsinki · FIHelsinki University Hospital · FIMax Planck Institute for Developmental Biology · DE

Funding

European Research Council 250172
6 · The paper itself

Abstract

backgroundInfants born by caesarean section or receiving antibiotics are at increased risk of developing metabolic, inflammatory and immunological diseases, potentially due to disruption of normal gut microbiota at a critical developmental time window. We investigated whether probiotic supplementation could ameliorate the effects of antibiotic use or caesarean birth on infant microbiota in a double blind, placebo-controlled randomized clinical trial. Mothers were given a multispecies probiotic, consisting of Bifidobacterium breve Bb99 (Bp99 2 × 10

resultsThe probiotic supplement had a strong overall impact on the microbiota composition, but the effect depended on the infant's diet. Only breastfed infants showed the expected increase in bifidobacteria and reduction in Proteobacteria and Clostridia. In the placebo group, both birth mode and antibiotic use were significantly associated with altered microbiota composition and function, particularly reduced Bifidobacterium abundance. In the probiotic group, the effects of antibiotics and birth mode were either completely eliminated or reduced.

conclusionsThe results indicate that it is possible to correct undesired changes in microbiota composition and function caused by antibiotic treatments or caesarean birth by supplementing infants with a probiotic mixture together with at least partial breastfeeding.

trial registrationclinicaltrials.gov NCT00298337 . Registered March 2, 2006.

Indexed as

Anti-Bacterial AgentsBifidobacteriumBreast FeedingCesarean SectionClostridiumDietary SupplementsDouble-Blind MethodFecesFemaleGastrointestinal MicrobiomeHumansInfantLacticaseibacillus rhamnosusMalePregnancyProbioticsAnti-Bacterial AgentsBifidobacteriaEarly-life microbiotaLactobacilliMetagenomicsMetaproteomics

Identifiers

PMID30326954
PMCPMC6192119
OpenAlexW2897452990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.